Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:AMSSYOTCMKTS:CLIGFOTCMKTS:FPLSFOTCMKTS:GETVY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMSSYams-OSRAM$4.75$4.47$2.85▼$7.86$948.53M0.7735 shsN/ACLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AFPLSF5N Plus$6.25-2.6%$5.56$2.00▼$7.00$556.78M1.8412,122 shs5,672 shsGETVYMediaset España Comunicación$3.76$3.76$3.40▼$4.14$1.18B-0.16250 shsN/AOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMSSYams-OSRAM0.00%0.00%0.00%-7.77%+578.57%CLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%FPLSF5N Plus0.00%-7.80%+5.95%+79.11%+44.70%GETVYMediaset España Comunicación0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMSSYams-OSRAMN/AN/AN/AN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AN/AN/AN/AFPLSF5N Plus0.6594 of 5 stars0.03.00.00.03.00.00.6GETVYMediaset España ComunicaciónN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMSSYams-OSRAM 4.00Strong BuyN/AN/ACLIGFClinigen Group 0.00N/AN/AN/AFPLSF5N Plus 0.00N/AN/AN/AGETVYMediaset España Comunicación 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMSSYams-OSRAM$3.71B0.26$5.11 per share0.93$6.69 per share0.71CLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77FPLSF5N Plus$289.28M1.92$0.40 per share15.71$1.56 per share4.01GETVYMediaset España Comunicación$943.42M1.25$1.14 per share3.30N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMSSYams-OSRAM-$850.53M-$1.62N/A3.60N/A-4.51%1.44%0.26%7/31/2025 (Estimated)CLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/AFPLSF5N Plus$14.67M$0.2426.05∞N/A6.94%18.49%6.92%8/4/2025 (Estimated)GETVYMediaset España Comunicación$204.16MN/A0.00∞N/AN/AN/AN/AN/ALatest FPLSF, GETVY, AMSSY, and CLIGF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025FPLSF5N Plus$0.0560$0.12+$0.0640$0.11$73.56 million$88.89 million4/30/2025Q1 2025AMSSYams-OSRAMN/A-$0.13N/A-$0.44N/A$862.61 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMSSYams-OSRAMN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AFPLSF5N PlusN/AN/AN/AN/AN/AGETVYMediaset España ComunicaciónN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMSSYams-OSRAM1.831.070.65CLIGFClinigen GroupN/AN/AN/AFPLSF5N Plus0.813.541.48GETVYMediaset España ComunicaciónN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMSSYams-OSRAMN/ACLIGFClinigen GroupN/AFPLSF5N Plus0.06%GETVYMediaset España ComunicaciónN/AInsider OwnershipCompanyInsider OwnershipAMSSYams-OSRAMN/ACLIGFClinigen GroupN/AFPLSF5N Plus3.94%GETVYMediaset España ComunicaciónN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMSSYams-OSRAM20,530199.69 millionN/ANot OptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableFPLSF5N Plus78089.07 million85.56 millionNot OptionableGETVYMediaset España Comunicación1,537313.17 millionN/ANot OptionableFPLSF, GETVY, AMSSY, and CLIGF HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comMedia Sentiment Over TimeFPLSF, GETVY, AMSSY, and CLIGF Company Descriptionsams-OSRAM OTCMKTS:AMSSY$4.75 0.00 (0.00%) As of 06/20/2025ams-OSRAM AG designs, manufactures, and sells LED and optical sensor solutions in Europe, the Middle East, Africa, the Americas, and Asia/Pacific. The company operates in Semiconductors and Lamps & Systems segments. The Semiconductors segment offers semiconductor-based products and solutions, such as high-performance LEDs, lasers, and optical sensors for automotive, consumer, and industrial and medical technology end markets. The Lamps & Systems segment provides lamps and lighting systems for the automotive, industrial, and medical end markets. The company was formerly known as ams AG and changed its name to ams-OSRAM AG in January 2022. ams-OSRAM AG is headquartered in Premstätten, Austria.Clinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.5N Plus OTCMKTS:FPLSF$6.25 -0.17 (-2.57%) As of 06/20/2025 10:47 AM Eastern5N Plus Inc. produces and sells specialty metals and chemicals in North America, Europe, and Asia. It operates through two segments, Specialty Semiconductors and Performance Materials. The company offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, and solar cells. It also provides active pharmaceutical ingredients, animal feed additives, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. The company serves renewable energy, security, space, pharmaceutical, medical imaging, manufacturing, electronic, consumer, and industrial application markets. 5N Plus Inc. is headquartered in Montreal, Canada.Mediaset España Comunicación OTCMKTS:GETVY$3.76 0.00 (0.00%) As of 05/12/2023Mediaset España Comunicación, S.A., together with its subsidiaries, engages in the television broadcasting business in Spain. The company operates seven television channels comprising TELECINCO, FactorÃa de Ficción, BOING, Cuatro, Divinity, Energy, and Be Mad. It is also involved in the production and broadcast of audiovisual content; provision of news agency services; exploitation of advertising space on television channels; and advertising promotion activities. The company was formerly known as Gestevisión Telecinco, S.A. and changed its name to Mediaset España Comunicación, S.A. in May 2011. Mediaset España Comunicación, S.A. was incorporated in 1989 and is based in Madrid, Spain. Mediaset España Comunicación, S.A. is a subsidiary of MFE-MediaForEurope NV. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
